C4 Therapeutics Ownership | Who Owns C4 Therapeutics?
C4 Therapeutics Ownership Summary
C4 Therapeutics is owned by 91.96% institutional investors, 11.43% insiders. Lynx1 capital management lp is the largest institutional shareholder, holding 10.00% of CCCC shares. Wasatch Ultra Growth is the top mutual fund, with 4.79% of its assets in C4 Therapeutics shares.
CCCC Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | C4 Therapeutics | 91.96% | 11.43% | -3.40% |
Sector | Healthcare Stocks | 88.01% | 8.90% | 3.09% |
Industry | Biotech Stocks | 109.70% | 8.77% | -18.47% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Lynx1 capital management lp | 6.88M | 10.00% | $31.79M |
Blackrock funding, inc. /de | 5.56M | 7.98% | $20.01M |
Ra capital management | 4.88M | 7.09% | $22.54M |
Wasatch advisors lp | 4.85M | 7.04% | $22.39M |
Blackrock | 4.55M | 6.61% | $21.03M |
Soleus capital management | 4.05M | 5.89% | $18.72M |
Commodore capital lp | 3.41M | 4.96% | $15.76M |
Vanguard group | 3.35M | 4.81% | $12.05M |
State street | 2.99M | 4.35% | $13.84M |
Balyasny asset management | 1.94M | 2.81% | $8.94M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Lynx1 capital management lp | 6.88M | 2.06% | $31.79M |
Soleus capital management | 4.05M | 1.65% | $18.72M |
Silverarc capital management | 1.44M | 1.57% | $6.67M |
Commodore capital lp | 3.41M | 1.08% | $15.76M |
Bain capital life sciences investors | 1.11M | 0.56% | $5.14M |
Ra capital management | 4.88M | 0.30% | $22.54M |
Vienna powszechne towarzystwo emerytalne s.a. vienna insurance group | 85.00K | 0.18% | $306.00K |
Orbimed advisors | 1.51M | 0.14% | $6.99M |
Wasatch advisors lp | 4.85M | 0.12% | $22.39M |
Tang capital management | 200.00K | 0.09% | $924.00K |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Blackrock | 4.55M | 0.00% | 3.65M |
Lynx1 capital management lp | 6.88M | 2.06% | 3.25M |
Soleus capital management | 4.05M | 1.65% | 1.59M |
Orbimed advisors | 1.51M | 0.14% | 1.51M |
Geode capital management | 1.36M | 0.00% | 851.90K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
State street | 2.99M | 0.00% | -4.16M |
Price t rowe associates inc /md/ | 62.31K | - | -2.05M |
Tcg crossover management | - | - | -1.28M |
Citigroup | 30.46K | 0.00% | -740.27K |
Rafferty asset management | 185.74K | 0.00% | -647.94K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Orbimed advisors | 1.51M | 0.14% | 1.51M | $6.99M |
Nuveen asset management | 431.01K | 0.00% | 431.01K | $1.99M |
Tang capital management | 200.00K | 0.09% | 200.00K | $924.00K |
Alliancebernstein | 45.78K | 0.00% | 45.78K | $211.50K |
Deutsche bank ag\ | 29.85K | 0.00% | 29.85K | $137.90K |
Sold Out
Holder | Change |
---|---|
Gradient investments | -25.00 |
Capital performance advisors llp | -54.00 |
Cape investment advisory | -100.00 |
Lindbrook capital | -100.00 |
Nisa investment advisors | -165.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Sep 30, 2024 | 126 | 5.88% | 64,029,825 | 5.20% | 91 | 1.18% | 67 | 1.52% | 33 | -2.94% |
Jun 30, 2024 | 119 | 7.21% | 60,865,031 | 4.84% | 88 | 1.23% | 66 | -1.49% | 34 | 25.93% |
Mar 31, 2024 | 111 | 16.84% | 58,053,690 | 23.80% | 84 | 1.01% | 67 | 21.82% | 27 | 8.00% |
Dec 31, 2023 | 95 | 15.85% | 46,893,581 | 35.38% | 91 | 1.85% | 55 | 44.74% | 25 | -16.67% |
Sep 30, 2023 | 82 | -16.33% | 34,638,219 | 1.31% | 70 | 1.45% | 38 | -25.49% | 30 | -16.67% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Wasatch Ultra Growth | 3.38M | 4.79% | 772.94K |
Vanguard Total Stock Mkt Idx Inv | 2.07M | 2.94% | - |
iShares Russell 2000 ETF | 1.68M | 2.38% | -12.75K |
SPDR® S&P Biotech ETF | 1.57M | 2.22% | 22.34K |
Biotech Growth Ord | 1.29M | 1.82% | - |
Vanguard Institutional Extnd Mkt Idx Tr | 808.90K | 1.15% | - |
Wasatch Micro Cap | 758.27K | 1.07% | -483.88K |
Fidelity Small Cap Index | 603.35K | 0.85% | 1.04K |
iShares Russell 2000 Value ETF | 542.31K | 0.77% | 738.00 |
Meridian Small Cap Growth Legacy | 481.88K | 0.68% | -18.74K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q1 | - | - |
2024 Q4 | - | - |
2024 Q3 | - | - |
2024 Q2 | - | - |
2024 Q1 | - | - |
CCCC Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools